Clinical Trial Update: Autologous Induced Pluripotent Stem Cells of Cardiac Lineage for Congenital Heart Disease [Phase 1]

View source ↗

Summary

This is a Phase 1 clinical trial sponsored by HeartWorks, Inc. evaluating autologous induced pluripotent stem cells of cardiac lineage for congenital heart dise…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Congenital Heart Disease
• Heart Failure
• Univentricular Heart

Drugs mentioned

• Autologous iPSC-derived cardiac lineage cells

Snippet

Sponsor: HeartWorks, Inc. | Conditions: Univentricular Heart, Congenital Heart Disease | Phase 1 | Status: RECRUITING